This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
OSA: Exploring the Impact on Morbidity and Mortality
Pre-Operative Vigilance: The Role of OSA Screening in Surgical Safety
Overcoming Hurdles: Effective OSA Screening in Primary Care
How to Screen for OSA
From Awareness to Action: What To Do With a Positive OSA Screen?
Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
Extending Treatment Durability With Next-Generation Neovascular AMD Therapies
Collaboration and Management of HE: Establishing Foundation for Successful Outcomes
Tackling the Unmet Need HEad On—What Does HE Look Like?
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video